Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report

Details werden geladen...

https://endpoints.news/amgen-stands-by-rare-disease-drug-tavneos-amid-japan-liver-toxicity-report/

Teilen bei Facebook
Teilen bei Twitter
Teilen bei Pinterest
Per Mail empfehlen

Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report

The FDA wants Amgen's Tavneos off the market. European regulators are investigating data-integrity concerns. And now, a pharma selling the drug in Japan is warning doctors against writing more prescriptions.

Amgen’s rare disease drug Tavneos tied to 20 deaths in Japan - BioSpace

https://www.biospace.com/business/amgens-rare-disease-drug-tavneos-tied-to-20-deaths-in-japan

Registrieren

Amgen stands by rare disease drug Tavneos amid Japan liver toxicity report

Ähnliche Seiten

Amgen’s rare disease drug Tavneos tied to 20 deaths in Japan - BioSpace